SGLT2 inhibitors and GLP-1 receptor agonists: a sound combination
- PMID: 29483059
- DOI: 10.1016/S2213-8587(18)30031-7
SGLT2 inhibitors and GLP-1 receptor agonists: a sound combination
Comment on
-
Dulaglutide as add-on therapy to SGLT2 inhibitors in patients with inadequately controlled type 2 diabetes (AWARD-10): a 24-week, randomised, double-blind, placebo-controlled trial.Lancet Diabetes Endocrinol. 2018 May;6(5):370-381. doi: 10.1016/S2213-8587(18)30023-8. Epub 2018 Feb 23. Lancet Diabetes Endocrinol. 2018. PMID: 29483060 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical